Improve Antimicrobial Stewardship and Patient Outcomes

Knowing whether a patient has a bacterial infection has a direct impact on reducing unnecessary antibiotic prescriptions, limiting the spread of antibiotic-resistant bacteria, and helping providers know when to initiate treatment.

FebriDx® is a rapid point-of-care test that uses a fingerstick blood sample to aid in the differentiation of bacterial from viral infection.  

This assay aids in the evaluation of infection by identifying and differentiating a clinically significant immune response to a suspected viral and/or bacterial infection in patients 1 year of age or older that present within 3 days of an acute onset fever (exhibited or reported) and within 7 days of new-onset respiratory symptoms consistent with a community-acquired acute respiratory infection.

FebriDx® is intended to be used in urgent and emergency care settings.

• All-in-one, Instrument-free test device
• Results in 10 minutes
• Sensitivity 95%/Specificity 94%
• NPV 99%/PPV 76%
  • Increase confidence in decision-making 
  • Confidently rule out a bacterial infection.
• Assists with outpatient antimicrobial stewardship programs.
• Ensure bacterial infections are not overlooked: Increased confidence in patient diagnosis.

This link is to the "Disrupt" study, the main publication for FebriDx US:

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797455

How it Works/Training Video:  https://vimeo.com/910250772?share=copy

Additional Information:

• Manufactured in the USA
• Categorized as a Moderate Complexity Laboratory Test NOT CLIA-Waived
• Target Audience: Primary Care, Urgent Care and Community Health Center
• Shelf Life: 

             FebriDx® Test Kit - 18 months from the date of manufacture

             FebriDx® External Controls - 10 months from the date of manufacture